Top Cancer Stocks in Sweden
Browse the largest Sweden companies in the world ranked by their Market Capitalization. Global Cancer Companies in Sweden market cap is $4.28B.
2 Sept 2024, 07:42 UTC
Companies: 25
🇸🇪1 |  | $6.82 | 1.15% | 2.61B | -15.13% | Underperform S&P500 YTD Benchamark | ⚕️ Healthcare | - |
🇸🇪2 |  | $0.86 | 3.78% | 738.25M | 1552.26% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇸🇪3 |  | $3.50 | 0.28% | 230.27M | 91.22% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇸🇪4 |  | $5.03 | 0.78% | 157.28M | 29.57% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇸🇪5 |  | $4.23 | 1.99% | 138.95M | 3.20% | Underperform S&P500 YTD Benchamark | ⚕️ Healthcare | - |
🇸🇪6 |  | $4.87 | 0.00% | 92.53M | 35.87% | Outperform S&P500 YTD Benchamark | 🩹 Medical devices | - |
🇸🇪7 |  | $0.13 | 4.43% | 84.54M | 91.58% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇸🇪8 |  | $0.39 | 1.32% | 71.27M | 6.58% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇸🇪9 |  | $0.28 | -9.09% | 45.58M | 291.89% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇸🇪10 |  | $0.74 | 11.43% | 33.26M | -42.65% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇸🇪11 |  | $0.24 | 2.89% | 23.53M | -34.99% | Underperform S&P500 YTD Benchamark | 🩹🏥 Medical equipment | - |
🇸🇪12 |  | $0.72 | 0.00% | 19.05M | 148.09% | Outperform S&P500 YTD Benchamark | 🩹 Medical devices | - |
🇸🇪13 |  | $0.22 | -2.54% | 18.25M | -49.84% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇸🇪14 |  | $0.31 | 1.27% | 17.28M | 1.02% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇸🇪15 |  | $0.04 | -0.33% | 15.77M | -1.86% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇸🇪16 |  | $0.02 | -3.03% | 13.41M | -37.10% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇸🇪17 |  | $0.61 | -1.08% | 12.15M | 10.26% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇸🇪18 |  | $0.13 | 2.58% | 9.20M | -21.96% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇸🇪19 |  | $0.26 | -0.56% | 8.91M | 2.91% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇸🇪20 |  | $0.11 | 5.45% | 7.96M | -42.86% | Underperform S&P500 YTD Benchamark | 🩹 Medical devices | - |
🇸🇪21 |  | $0.03 | -1.88% | 6.67M | -6.27% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇸🇪22 |  | $0.10 | -0.46% | 5.96M | 112.87% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇸🇪23 |  | $0.09 | -5.40% | 3.86M | -50.79% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇸🇪24 |  | $0.17 | -8.21% | 3.45M | -61.00% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇸🇪25 |  | $0.19 | 0.00% | 3.11M | -27.41% | Underperform S&P500 YTD Benchamark | ⚕️ Healthcare | - |
